The landscape of aesthetic medicine is poised for significant advancements with the introduction of new botulinum toxins, according to Giovanni Salti, president of the Italian Association of Botulinum Aesthetic Therapy (AITEB). Speaking at a recent congress in Bologna, Salti highlighted the growing array of botulinum toxins that have received approval in recent years, along with many others currently in development. He emphasized that these innovations will broaden the therapeutic applications of botulinum toxins, allowing for targeted treatments of organs that have not traditionally been addressed.
During the congress, experts discussed several key innovations in the use of botulinum toxin, including its diverse applications and the integration of advanced techniques such as ultrasound and electromyography. Salti noted that recent anatomical studies have enhanced the understanding of muscle structures and neuromuscular junctions, paving the way for more effective treatments. He specifically mentioned the promising results from trials involving full face and neck treatments, which aim to achieve muscle harmony and balance.
One notable development is the recent approval in the United States for the use of cosmetic botulinum toxin to treat neck muscle bands. Salti expressed optimism that, given the positive outcomes observed in clinical trials, similar approvals will soon follow in Europe. This progression underscores the potential for botulinum toxins to not only enhance aesthetic outcomes but also to expand their role in medical therapies, signaling a new era for practitioners and patients alike.
Related topic
